Miscusi Massimo, Trungu Sokol, Ricciardi Luca, Forcato Stefano, Mangraviti Antonella, Raco Antonino
Department of Neurosurgery, Sant'Anna University Hospital, 44121 Ferrara, Italy.
Neurosurgery Unit, Cardinale G. Panico Hospital, 73039 Tricase, Italy.
J Clin Med. 2024 Jun 12;13(12):3444. doi: 10.3390/jcm13123444.
: Standard oblique cages cannot cover endplates side-to-side, which is an important biomechanical factor for reducing the risk of cage subsidence and for restoring correct segmental lordosis. The aim of this study is to evaluate the radiological and clinical results of a new oblique lumbar interbody fusion (OLIF) axially expandable cage. : This is a prospective observational case-control study. From March 2018 to June 2020, 28 consecutive patients with lumbar degenerative disease underwent an ATP approach, with the insertion of a new axially expandable cage, which was used as a stand-alone procedure or followed by posterior percutaneous pedicle fixation. : Twenty-eight patients in both groups met the inclusion criteria. The mean follow-up time was 31.2 months (range of 13-37). The clinical results were not significantly different, although in the control group, two major intraoperative complications were recorded, and slight improvements in ODI and SF-36 scores were observed in the study group. The radiological results showed a less frequent incidence of subsidence and a higher rate of fusion in the study group compared to controls. : The axially expandable oblique cage for lumbar inter body fusion, specifically designed for the ATP approach, represents an innovation and a technical improvement. The insertion and the axial expansion technique are safe and easy. The large footprint could obtain solid and effective arthrodesis, potentially reducing the risk of subsidence.
标准斜向椎间融合器无法从一侧到另一侧覆盖终板,这是降低椎间融合器下沉风险和恢复正确节段前凸的一个重要生物力学因素。本研究的目的是评估一种新型轴向可扩张斜向腰椎椎间融合(OLIF)椎间融合器的影像学和临床结果。
这是一项前瞻性观察性病例对照研究。从2018年3月至2020年6月,28例连续的腰椎退行性疾病患者接受了腋中线经腹膜外(ATP)入路,植入了一种新型轴向可扩张椎间融合器,该手术可单独进行,也可在术后进行经皮后路椎弓根固定。
两组的28例患者均符合纳入标准。平均随访时间为31.2个月(范围13 - 37个月)。临床结果无显著差异,尽管在对照组中记录到2例主要术中并发症,且研究组的腰椎功能障碍指数(ODI)和36项简短健康调查(SF - 36)评分有轻微改善。影像学结果显示,与对照组相比,研究组下沉发生率较低,融合率较高。
专门为ATP入路设计的轴向可扩张斜向腰椎椎间融合器是一项创新和技术改进。其植入和轴向扩张技术安全且简便。较大的接触面积可实现坚实有效的关节融合,可能降低下沉风险。